1 |
Choi HS, The Steroid Receptors: Molecular Mechanism of Action. Korean Endocrine Society. 2000;15(3).
|
2 |
Lee EK, Park YJ. Metabolic regulation of nuclear receptors. Journal of Korean Endocrine Society. 2008;23(3):155-164.
DOI
|
3 |
Bae YI, Seo KI, Park SK, Shim KH. Loquat (Eriobotrya japonica Lindl.) Leaf Tea Processing and Its Physicochemical Properties. Korean J. Postharvest Sci Technol. 1998;5(3):262-269.
|
4 |
Kim SJ, Park JO, Park SN. Antioxidative Effect and Component Analysis of Eriobotrya japonica Leaf Extracts. J Soc. Cosmet. Sci. Korea. 2012;38(1):57-65.
DOI
|
5 |
Kim SM, Kim AY, Lee KI. Nitric Oxide Production Inhibitory Effects of Three Caffeoylquinic Acids Isolated from Hot Water Extract of Eriobotrya japonica L. Leaves. Korean J. Medicinal Crop Sci. 2020;28(4):245-253.
DOI
|
6 |
Lee H, Kim YK, Lee HJ, Lee JJ. Effects of Loquat (Eriobotrya japonica Lindl.) Ethanol Extracts of Different Aerial Parts on Antioxidant Activity and Antiproliferation of Human Cancer Cells. Korean J Community Living Sci. 2016;27(2):211~220.
DOI
|
7 |
De Tommasi N, De Simone F, Pizza C, Mahmood N, Moore PS, Conti C et al. Constituents of Eriobotrya japonica. A Study of Their Antiviral Properties. J. Nat. Prod. 1992;55(8):1067-1073.
DOI
|
8 |
Lee WK, Choi YY, Yang WM. Effect of Eriobotrya folium on Local Fat via Regulation of Lipase Secretion. Journal of Korean Medicine for Obesity Research. 2017;17(2):101-110.
DOI
|
9 |
Yun UJ, Bae SJ, Song YR, Kim YW. A Critical YAP in Malignancy of HCC Is Regulated by Evodiamine. Int J Mol Sci. 2022 Feb 6;23(3):1855.
|
10 |
Beltowski J. Liver X receptors (LXR) as therapeutic targets in dyslipidemia. Cardiovasc Ther. 2008;26(4):297-316.
DOI
|
11 |
Repa JJ, Liang G, Ou J, Bashmakov Y, Lobaccaro1 JMA, Shimomura I, et al. Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ. Genes & Dev. 2000;14(22):2819-2830.
DOI
|
12 |
Apfel R, Benbrook D, Lernhardt E, Ortiz MA, Salbert G, Pfahl M. A Novel Orphan Receptor Specific for a Subset of Thyroid Hormone-Responsive Elements and Its Interaction with the Retinoid/Thyroid Hormone Receptor Subfamily. Molecular and cellular biology. 1994;14(10):7025-7035.
DOI
|
13 |
Song C, Kokontis JM, Hiipakka RA, Liao S. Ubiquitous receptor: A receptor that modulates gene activation by retinoic acid and thyroid hormone receptors. Proc. Nati. Acad. Sci. 1994;91(23):10809-10813.
DOI
|
14 |
Ferre P, Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c. Diabetes, Obesity and Metabolism. 2010;12(s2):83-92.
DOI
|
15 |
Kohjima M, Higuchi N, Kato M, Kotoh K, Yoshimoto T, Fujino T. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. In J. Molecular Medicine. 2008;21(4);507-511.
|
16 |
Yap F, Craddock L, Yang J. Mechanism of AMPK Suppression of LXR-dependent Srebp-1c transcription. Int J Biol Sci. 2011;7(5):645-650.
DOI
|
17 |
Ferre P, Phan F, Foufelle F. SREBP-1c and lipogenesis in the liver: an update. Biochem J. 2021;478(20):3723-3739.
DOI
|
18 |
Yin W, Mu J, Morris JB. Role of AMP-activated Protein Kinase in Cyclic AMP-dependent Lipolysis In 3T3-L1 Adipocytes. Journal of Biological Chemistry. 2003;278(44):43074-43080.
DOI
|
19 |
Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumor suppression. Nat Rev Cancer. 2009;9(8):563-575.
DOI
|
20 |
Mhairi C Towler, D Grahame Hardie. AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling. Circ. Res. 2007;100(3):328-341.
DOI
|
21 |
Hardie DG. The AMP-activated protein kinase pathway - New players upstream and downstream. Journal of Cell Science. 2004;117(23):5479-5487.
DOI
|
22 |
Brunt EM. Pathology of fatty liver disease. Modern Pathology. 2007;20(1):S40S48.
|
23 |
Dogliotti G, Kullmann L, Dhumale P, Thiele C, Panichkina O, Mendl G, et al. Membrane-binding and activation of LKB1 by phosphatidic acid is essential for development and tumour suppression. Nature Communications. 2017;8(1):1-12.
DOI
|
24 |
Park YC, Park HM, Lee SD. Inducible Mechanisms for Hepatotoxicity caused by Traditional Korean Medicines in a view of Toxicology. Journal of Korean Medicine. 2011;32(4);48-67.
|
25 |
Chung KW. Ultrastructure of chronic liver diseases: From light to electron microscopy. Clinical and Molecular Hepatology. 2002;8(1):112-123.
|
26 |
Yoon SK. Diagnosis and treatment of fatty liver. Korean Journal of Medicine. 2009;76(6):677-679.
|
27 |
Kim CY, Moon SM, Hyun KY, Kim DS, Choi SC. Difference in Serum Iron, Cardiac, and Biochemical Indices between Alcoholic and Non-alcoholic Fatty Liver. Journal of Life Science. 2009;19(2):185-191.
DOI
|